Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000-10,000 IU/L: Phase II Open Label, Single Arm Multi-Centre Trial. (2018)

First Author: Skubisz MM
Attributed to:  MRC Centre for Reproductive Health at the University of Edinburgh funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2018.06.017

PubMed Identifier: 29941341

Publication URI: http://europepmc.org/abstract/MED/29941341

Type: Journal Article/Review

Volume: 33

Parent Publication: EBioMedicine

ISSN: 2352-3964